Part the Cloud Translational Research for Alzheimer’s Disease Program
Alzheimer's Association
This program increases the research efforts in Phase I and Phase II (Proof of Concept) clinical trials evaluating novel or repurposed potential medications directed towards Alzheimer’s disease and related dementias internationally.
Each grant is limited to $1,000,000 (direct and indirect costs) over two or three years.
Deadlines
UM Internal Deadline | Sponsor Deadline | |
---|---|---|
Letter of Intent |
| 06-Aug-2025 5:00 pm EST |
Application | 04-Sep-2025 4:30 pm CST | 24-Sep-2025 5:00 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.